178 related articles for article (PubMed ID: 37328332)
1. Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism.
Tseng CS; Chan CK; Lee HY; Pan CT; Peng KY; Wang SM; Huang KH; Tsai YC; Wu VC; Chueh JS;
J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S125-S134. PubMed ID: 37328332
[TBL] [Abstract][Full Text] [Related]
2. Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism.
Huang KH; Yu CC; Hu YH; Chang CC; Chan CK; Liao SC; Tsai YC; Jeff Chueh SC; Wu VC; Lin YH;
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):72-82. PubMed ID: 29506889
[TBL] [Abstract][Full Text] [Related]
3. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Funder JW; Carey RM; Mantero F; Murad MH; Reincke M; Shibata H; Stowasser M; Young WF
J Clin Endocrinol Metab; 2016 May; 101(5):1889-916. PubMed ID: 26934393
[TBL] [Abstract][Full Text] [Related]
4. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
[TBL] [Abstract][Full Text] [Related]
5. [Primary aldosteronism: from diagnosis to therapy in clinical practice].
Vetri M; Cassaniti L; Francese GM; Gulizia MM
G Ital Cardiol (Rome); 2021 Apr; 22(4):319-326. PubMed ID: 33783452
[TBL] [Abstract][Full Text] [Related]
6. Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection.
Chan CK; Chang YY; Tsai YC; Chen ZW; Wu CY; Huang WC; Yen IW; Wu KH; Wu VC; Lin YH;
J Formos Med Assoc; 2021 Oct; 120(10):1811-1820. PubMed ID: 33906783
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism.
Wachtel H; Fraker DL
Curr Cardiol Rep; 2021 Jun; 23(7):89. PubMed ID: 34081226
[TBL] [Abstract][Full Text] [Related]
8. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.
Williams TA; Reincke M
Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
10. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Weiner ID
Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
[TBL] [Abstract][Full Text] [Related]
11. Primary aldosteronism: Practical recommendations for treatment and follow-up.
Araujo-Castro M; Pascual-Corrales E; Martín Rojas P; Parra Ramírez P
Hipertens Riesgo Vasc; 2023; 40(4):215-221. PubMed ID: 37993292
[TBL] [Abstract][Full Text] [Related]
12. Advances in Medical Treatment of Primary Aldosteronism.
Li YJ; Ji ZG; Wen J
Chin Med Sci J; 2023 Mar; 38(1):49-56. PubMed ID: 36642703
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of primary aldosteronism.
Vilela LAP; Almeida MQ
Arch Endocrinol Metab; 2017; 61(3):305-312. PubMed ID: 28699986
[TBL] [Abstract][Full Text] [Related]
14. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 6: Adrenal surgery.
Steichen O; Amar L; Chaffanjon P; Kraimps JL; Ménégaux F; Zinzindohoue F
Ann Endocrinol (Paris); 2016 Jul; 77(3):220-5. PubMed ID: 27297451
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.
Katabami T; Fukuda H; Tsukiyama H; Tanaka Y; Takeda Y; Kurihara I; Ito H; Tsuiki M; Ichijo T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Yanase T; Suzuki T; Naruse M;
J Hypertens; 2019 Jul; 37(7):1513-1520. PubMed ID: 31145370
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in the diagnosis and treatment of primary aldosteronism.
Yoshida Y; Shibata H
Hypertens Res; 2023 Jul; 46(7):1738-1744. PubMed ID: 37198444
[TBL] [Abstract][Full Text] [Related]
17. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
[TBL] [Abstract][Full Text] [Related]
18. Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.
Hundemer GL
Curr Cardiol Rep; 2019 Jul; 21(9):93. PubMed ID: 31352525
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism.
Satoh M; Maruhashi T; Yoshida Y; Shibata H
Hypertens Res; 2019 Jun; 42(6):817-824. PubMed ID: 30948836
[TBL] [Abstract][Full Text] [Related]
20. Personalized Treatment of Patients With Primary Aldosteronism.
Obeid H; Chen Cardenas SM; Khairi S; Turcu AF
Endocr Pract; 2023 Jun; 29(6):484-490. PubMed ID: 36273684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
